Gulf Oil Lubricants India Limited (GOLIL) is celebrating its 125th anniversary with an ambitious growth and transformation agenda. The company is focusing on expanding its manufacturing capacity and investing in sustainable technologies, including EV charging infrastructure. The milestone was marked with a special event in Mumbai featuring top customers, distributors, and partners, including Chairman Mr. Sanjay Hinduja and brand ambassadors MS Dhoni and Smriti Mandhana.

Accelerated Growth and Transformation

As part of its 125-year celebrations, Gulf Oil is targeting a 70% increase in manufacturing capacity to 240 million litres by March 2027. The company is also investing in charging hardware, software, and connectivity for the evolving mobility landscape. This transformation includes digitalisation, sustainability, and last-mile engagement to strengthen its core lubricants business and expand into future-ready mobility solutions.

Commitment to Sustainable Development

Gulf Oil has pledged to lead empowerment, circular economy, and sustainable development. As part of the 125-year celebrations, the company launched the “Generation Behad” initiative to empower 125,000 women in mobility. The initiative aims to provide knowledge and mobility career opportunities for women, including roles as drivers and mechanics. This commitment underscores Gulf Oil’s dedication to inclusive growth and sustainable development.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Gulf Oil Lubricants India Limited

Gulf Oil Lubricants India Limited belongs to the Basic Materials › Specialty Chemicals sector. Here’s a quick read on where the business and the stock stand today.

Gulf moves sideways over three months, with neither buyers nor sellers taking control. D/E stands at 0.00 with a 4.79% dividend yield. Furthermore, the business records zero revenue dips and zero loss quarters in five years — a fortress balance sheet. Thin margins at 8.6% leave limited room for error — any demand softness or cost spike hits the bottom line hard. The stock holds at 53% of its 52-week range with RSI at 51. In other words, neither side has a clear edge right now. Both the business and the stock move in the right direction. Revenue grows at 10.6%, profits at 14.4%, and the PEG sits at 1.01 — below its growth rate. That combination is rare. Check Fundamentals of Gulf Oil Lubricants India Limited.

Solar Industries India Limited (SIIL) today announced its unaudited financial results for the quarter and half year ended September 30, 2026. The company reported consolidated revenue of ₹3519 crore in Q2 FY27, representing growth of 69% year-on-year, and ₹7187 crore in H1 FY27, representing growth of 70% year-on-year.

Key Financial Highlights

The company’s EBITDA stood at ₹1021 crore in Q2 FY27, with an EBITDA margin of 29.02%, and ₹2045 crore in H1 FY27, with a margin of 28.45%. Profit after tax (PAT) was ₹650 crore in Q2 FY27 and ₹1316 crore in H1 FY27. The order book stood at ₹20178 crore, providing visibility for future execution.

Business Segment Performance

Commenting on the performance, Mr. Manish Nuwal, Managing Director and CEO, said: “We are pleased to report another quarter of strong and broad-based performance. The results reflect the resilience of our business model, disciplined execution and the benefits of our strategic investments.”

Domestic Explosives delivered a healthy performance during the quarter, supported by demand from the mining and infrastructure sectors, stronger customer engagement, an expanded manufacturing footprint, and technical-service capabilities.

The International Explosives business maintained its momentum, supported by deeper customer relationships, improved market penetration, and sustained demand across key operating geographies. The Defence business continued to grow, supported by execution of the existing order book, an expanding portfolio of indigenously developed products, and opportunities in domestic and international markets.

Concluding the performance update, Mr. Nuwal said: “The Company’s first-half performance, together with momentum across Domestic Explosives, International Explosives, and Defence, has reinforced our confidence in its growth trajectory. We expect to surpass our stated annual guidance for FY2026-27. Our expanding manufacturing footprint, disciplined capital allocation, technology-led product development, and broader presence in domestic and international markets provide a foundation for sustainable growth.”

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Solar Industries India Limited

Solar Industries India Limited belongs to the Basic Materials › Specialty Chemicals sector. Here’s a quick read on where the business and the stock stand today.

Solar rises 8.4% over three months, with buying pressure holding steady. The PEG of 2.99 is on the high side. However, it is acceptable for a quality compounder with a strong moat. Revenue grows at 12.4% and profits at 30.4% CAGR. The market consistently rewards this kind of compounding. The stock trades at 76% of its 52-week range — near its best levels of the year. Clearly, the market pays a premium for this name. The business grows revenue at 12.4% and profits at 30.4%, with D/E of 0.00. The stock reflects that strength. Moreover, when fundamentals and price action align, the PEG of 2.99 premium is usually justified. Check Fundamentals of Solar Industries India Limited.

Balaji Amines Limited (BALAMINES) announced its unaudited financial results for the quarter and half year ended September 30th, 2026. The consolidated revenue for Q2 FY27 stood at ₹472 crore, up from ₹348 crore in Q2 FY26. The EBITDA was ₹106 crore compared to ₹67 crore in the same quarter last year. Net profit for the quarter was ₹67 crore, significantly higher than the ₹37 crore reported in Q2 FY26.

Financial Performance

The company’s total revenue for Q2 FY27 was ₹472 crore, a notable increase from ₹348 crore in Q2 FY26. The EBITDA margin stood at 22%, down from 26% in Q1 FY27 but up from 19% in Q2 FY26. The profit after tax (PAT) for the quarter was ₹67 crore, up from ₹37 crore in the previous year’s quarter. Diluted earnings per share (EPS) for Q2 FY27 stood at ₹20.76 per equity share, compared to ₹10.67 in Q2 FY26.

Growth Drivers

The company continues to strengthen its growth platform through capacity expansion and a focus on value-added specialty chemicals. Commercial production has commenced at the expanded Acetonitrile (ACN) facility, increasing installed capacity to 1,440 TPM. The upgraded plant incorporates advanced technology and enhanced process efficiencies, positioning the company to improve operational performance over the medium term.

The successful commissioning of the 100,000 TPA Dimethyl Ether (DME) plant, India’s first commercial-scale DME facility, has established the company in a high-potential import substitution market with applications spanning healthcare, personal care products, and fuel applications. The next phase of work is in the pipeline to establish a robust network of customers as the company has already studied the ever-expanding Aerosol market. Opportunities for export of DME are explored regularly.

The next product planned for commercialization is N-Methyl Morpholine (NMM), further expanding the specialty chemicals portfolio. In parallel, Balaji Speciality Chemicals is progressing with its expansion program that is aimed at increasing the share of high-value specialty chemicals. The Unit-I brownfield expansion, comprising EDA derivatives such as DETA, TETA, Piperazine, AEEA, and AEP, remains on track for commissioning during the end of FY27. The Unit-II greenfield project at MIDC, Chincholi, which will manufacture HCN, NaCN, EDTA, and EDTA-2Na, is targeted for commissioning in Q4 FY27.

On the performance, Mr. D. Ram Reddy, Managing Director, commented, ‘Q2 FY27 reflected resilient execution and steady progress on our strategic priorities. As we enter H2 FY27, our focus is firmly on driving higher utilization, improving operating efficiencies and translating recent investments into stronger earnings growth. The commissioning of the upgraded Acetonitrile (ACN) facility and the DME plant marks an important step in expanding our presence in value-added and import-substitution products. We are now focused on scaling these capacities and unlocking their full commercial potential. We have also improved the process of Di Isopropylamine (DIPA) as continuous efforts yielded this success. Overall, the volumes have dented due to various external factors, however, the company has leveraged its strength in stabilising the product portfolio to keep the top line stable and continuing the efforts to strengthen the bottom line. Our growth pipeline remains robust, with N-Methyl Morpholine (NMM) and multiple specialty chemical projects progressing as planned. These investments will further strengthen our specialty chemicals portfolio, enhance integration and expand our participation in high-growth end markets. With a stronger product mix, a visible expansion roadmap and a disciplined focus on execution, we remain confident in our ability to drive sustainable growth, improve earnings quality and create long-term value for shareholders.’

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Balaji Amines Limited

Balaji Amines Limited belongs to the Basic Materials › Specialty Chemicals sector. Here’s a quick read on where the business and the stock stand today.

Balaji falls 9.7% over three months and has not found a floor yet. Revenue contracts at -15.6% CAGR. That signals structural headwinds, not a short-term blip. The stock holds at 66% of its 52-week range with RSI at 45. In other words, neither side has a clear edge right now. The stock holds up despite -15.6% revenue growth and a PEG of 99.00. That could signal an early turnaround. Alternatively, index flows simply support the price. Watch whether analysts revise estimates upward — that is the real signal. Check Fundamentals of Balaji Amines Limited.